Quantinuum Finalizes $100M CHIPS Act Award & Issues 2.37M Shares to U.S. Dept of Commerce
Quantinuum Inc.
Subscribe to track QNT
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
📢 Quantinuum Inc. ($QNT) filed an 8-K announcing the finalization of a $100.0M CHIPS Act R&D Award with the U.S. Department of Commerce.
• Total Award: Up to $100.0M ($56.0M initial disbursement; $32.0M and $12.0M upon reaching milestones) • Equity Consideration: Issued 2,369,528 Class A Common shares to the Department of Commerce • Project Focus: Scaling trapped-ion quantum computing hardware, R&D in integrated photonics (422 nm), cryogenic ASICs, and optical packaging • Partnerships: Teaming up with GlobalFoundries and Monarch Quantum for domestic component manufacturing and fabrication.
Comprehensive Analysis
Summary of Material Event
On September 4, 2026, Quantinuum LLC (a subsidiary of Quantinuum Inc., NASDAQ: QNT) entered into an Other Transaction Agreement (the "Award Agreement") with the U.S. Department of Commerce under the CHIPS Act of 2022. On September 8, 2026, Quantinuum finalized a Securities Issuance Agreement granting equity consideration to the Department of Commerce in connection with the award.
Key Terms of the Award & Securities Issuance
-
Funding Structure:
- Total Potential Amount: Up to $100.0 million.
- Disbursement Schedule:
- $56.0 million available on or around the Award Date.
- $32.0 million milestone-based tranche.
- $12.0 million final milestone-based tranche.
- Use of Proceeds: Strictly for eligible research and development project costs consistent with an approved budget plan.
-
Securities Issued:
- Shares Issued: 2,369,528 shares of Class A common stock issued to the Department of Commerce.
- Exemption: Relying on Section 4(a)(2) and Section 4(a)(1½) exemptions from registration under the Securities Act of 1933.
- Registration Rights: Quantinuum agreed to file a shelf registration statement within 3 months for resale of the shares, with limitations to at most one underwritten offering in any 12-month period.
-
Covenants & Restrictions:
- Domestic Production & IP Nexus: Subject inventions must be predominantly manufactured or licensed for production in the U.S. during the 5-year performance period and for 10 years thereafter.
- Foreign Entity Restrictions: Prohibition against transferring, licensing, or selling Project IP to foreign countries/entities of concern.
- Clawback & Repurchase Provisions: The Department of Commerce maintains clawback rights (in debt format) for material non-compliance with domestic controls. If the agreement is terminated for convenience by the Department of Commerce, Quantinuum may repurchase unearned shares at an aggregate price of $1.00.
- Voting Restrictions: The Department of Commerce agreed not to vote its shares except on core matters altering share capitalization or rights adversely.
Strategic & Commercial Impact
- Manufacturing & Supply Chain Alliances: Quantinuum is partnering with GlobalFoundries (enlisted for 300mm wafer fabrication of next-gen ion traps and cryogenic control ASICs) and Monarch Quantum (manufacturing lasers and integrated photonics at 422 nm).
- Validation: Quantinuum is the only trapped-ion quantum computing architecture company selected for CHIPS R&D funding, reinforcing its positioning in scalable, fault-tolerant quantum computing.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
